40
Participants
Start Date
December 27, 2018
Primary Completion Date
May 24, 2019
Study Completion Date
May 24, 2019
Sonidor®
Sonidor® triple layer release tablets are developed with a specialized process to improve stability and bioavailability of the formulation based on hawthorn, lavender and hop extracts. The hawthorn, lavender and hop extracts used to product Sonidor® have an elevated content of vitexin (3%), monoterpens (4% as linalool) and flavonoids (4%), respectively.
Fizio Center, Timișoara
Lead Sponsor
Opera CRO, a TIGERMED Group Company
OTHER
Italfarmaco
INDUSTRY